Pricing Log in Create free account

Allogene Therapeutics, Inc. (ALLO) vs Tectonic Therapeutic, Inc. (TECX)

Allogene Therapeutics, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Tectonic Therapeutic, Inc. are of similar size ($379.7M and $376.6M). Tectonic Therapeutic, Inc. has the higher net margin (0.00% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 13 metrics below, Tectonic Therapeutic, Inc. leads on 10 and Allogene Therapeutics, Inc. on 3.

Valuation

Metric ALLO TECX Biotechnology median
P/E n/m n/m 10.60
P/S 72.71 n/m 9.40
P/B 0.78 1.75 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.02 n/m 9.02
Earnings yield (64.42%) (22.16%) (32.88%)
Free cash flow yield (29.99%) (18.51%) (23.13%)

Profitability

Metric ALLO TECX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (3,832.45%) 0.00% 0.00%
Net margin (3,517.41%) 0.00% 0.00%
Free cash flow margin (2,180.62%) 0.00% 0.00%
Return on equity (42.39%) (33.80%) (51.96%)
Return on assets (32.43%) (32.23%) (46.06%)
Return on invested capital (108.81%) 0.00% 0.00%

Growth

Metric ALLO TECX Biotechnology median
Revenue growth (TTM) 7,613.11% — 6.76%
EPS growth (last fiscal year) 34.09% 40.70% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLO TECX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.72 22.29 4.97
Net debt to EBITDA 1.24 3.08 1.01

Dividend

Metric ALLO TECX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALLO TECX Biotechnology median
Market cap 376.58m 379.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack